.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Moodys
Baxter
Fish and Richardson
Cerilliant
AstraZeneca
McKinsey
Healthtrust
Mallinckrodt
Federal Trade Commission

Generated: November 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,329,159

« Back to Dashboard

Claims for Patent: 8,329,159

Title:Hepatitis C virus inhibitors
Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Inventor(s): Belema; Makonen (North Haven, CT), Nguyen; Van N. (New Britain, CT)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:11/835,462
Patent Claims: 1. A compound which is methyl ((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S) -2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol- -5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpr- opyl)carbamate; or a pharmaceutically acceptable salt thereof.

2. A compound which is (1R,1'R)-2,2'-(4,4'-biphenyldiylbis(1H -imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl))bis(N,N-dimethyl-2-oxo-1-phe- nylethanamine); or a pharmaceutically acceptable salt thereof.

3. A compound which is methyl ((1S)-2-((2S)-2-(5-(4'-(2-((2S)-1-((2R)-2-(diethylamino)-2-phenylacetyl)-- 2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl) -1H-imidazol-2-yl)-1-pyrrolidinyl)-1-methyl-2-oxoethyl)carbamate; or a pharmaceutically acceptable salt thereof.

4. A compound which is methyl ((1R)-2-oxo-1-phenyl-2-((2S)-2-(5-(4'-(2-((2S)-1-((2R)-tetrahydro-2-furan- ylcarbonyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-- yl)-1-pyrrolidinyl)ethyl)carbamate; or a pharmaceutically acceptable salt thereof.

5. A compound which is methyl ((1R)-2-((2S)-2-(5-(4'-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)- -2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrro- lidinyl)-2-oxo-1-phenylethyl)carbamate; or a pharmaceutically acceptable salt thereof.

6. A compound which is dimethyl (4,4'-biphenyldiylbis(1H -imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl((1R)-2-oxo-1-phenyl-2,1-ethan- ediyl)))biscarbamate; or a pharmaceutically acceptable salt thereof.

7. A compound which is (1R)--N,N-dimethyl-2-oxo-1-phenyl-2-((2S) -2-(5-(4'-(2-((2S)-1-((2R)-tetrahydro-2-furanylcarbonyl)-2-pyrrolidinyl)-- 1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)ethanamin- e; or a pharmaceutically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Accenture
Harvard Business School
Healthtrust
Chinese Patent Office
McKinsey
AstraZeneca
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot